Current Applications of Nanobiomaterials, Volume 1: Exploring Sustainable Synthesis, Characterization, and Therapeutic Innovations in Nanomedicine
暫譯: 奈米生物材料的當前應用，第1卷：探索可持續合成、特徵化及奈米醫學中的治療創新
Arunachalam, Karuppusamy, Anand, Krishnan, Kumar, Sathish Sundar Dhilip
相關主題
商品描述
Biomaterials play a vital role in medicine today, including restoring function and facilitating diagnosis and disease prevention. Biomaterial-based products consist of either natural or synthetic materials. Biomaterials derived from natural products can consist of materials such as proteins, polysaccharides, lipids, glycoproteins, lipoproteins, cellular matrix, and its components. These products may be used as alternatives to animal-derived and synthetic chemical products to develop new therapeutic and diagnostic approaches with greater eco-friendliness and sustainability, according to new research. They are also biocompatible, biodegradable, renewable, non-toxic, and capable of remodelling.
Recently, scientists have been exploring the potential use of plant-based cellular matrix-based biomaterials for the treatment of various communicable and noncommunicable diseases, a trend that has attracted the attention of global biomedical research. Globally, there has been an increase in the need for more effective treatment and diagnostics as a result of the overwhelming disease burden in society. Current Applications of Nanobiomaterials, Volume 1 and Volume 2 together, outline the most widely used biomaterials derived from non-animal natural resources, such as plants, fungi, algae, and microbes, with a focus on novel therapeutic and diagnostic applications.
商品描述(中文翻譯)
生物材料在當今醫學中扮演著至關重要的角色，包括恢復功能、促進診斷和疾病預防。基於生物材料的產品可以由天然或合成材料組成。來自天然產品的生物材料可以包括蛋白質、多醣類、脂質、糖蛋白、脂蛋白、細胞基質及其組成部分。根據最新研究，這些產品可以作為動物來源和合成化學產品的替代品，以開發更具環保性和可持續性的新的治療和診斷方法。它們還具有生物相容性、生物可降解性、可再生性、無毒性和重塑能力。
最近，科學家們一直在探索基於植物的細胞基質生物材料在治療各種傳染性和非傳染性疾病中的潛在應用，這一趨勢引起了全球生物醫學研究的關注。隨著社會中疾病負擔的加重，對更有效的治療和診斷的需求在全球範圍內不斷增加。《當前納米生物材料應用，第一卷和第二卷》共同概述了最廣泛使用的來自非動物天然資源的生物材料，如植物、真菌、藻類和微生物，重點介紹了新穎的治療和診斷應用。
作者簡介
Dr. Karuppusamy Arunachalam, Visiting Professor at CeTroGen, UFMS, Brazil, with expertise in ethnobotany, ethnopharmacology, biotechnology, and preclinical pharmacology, focusing on herbal drug development. He previously held a postdoctoral fellowship at UFMT, Brazil, and was awarded the prestigious PIFI fellowship at the Kunming Institute of Botany, CAS, China, in 2020. His recent research emphasizes natural products, phytochemistry, nutraceuticals, and polysaccharides. He has authored over 50 peer-reviewed articles, 5 books (including 3 with Springer Nature), 7 book chapters, and holds 5 patents (4 international and 1 national).
Dr. Krishnan Anand is a Senior Lecturer at the University of the Free State, South Africa, with expertise in organic chemistry, medical biochemistry, drug discovery, and nanobiotechnology. He earned his PhD from Durban University of Technology in collaboration with the University of KwaZulu-Natal in 2014. He has held postdoctoral and senior research roles in South African institutions and received the prestigious DSI-NRF Innovation Postdoctoral Fellowship. With over 2,300 citations and an h-index of 26, he has published extensively, including 7 books and 20 book chapters. He has received several national and international awards and holds a Y1 NRF researcher rating.
Dr. Sathish Sundar Dhilip Kumar is a C2-rated nanobiotechnology researcher at South Africa's National Research Foundation and Senior Lecturer at the Laser Research Centre, University of Johannesburg. A certified Professional Natural Scientist (SACNASP) and member of the Royal Society of Biology (UK), his work focuses on nanoparticle applications in photobiomodulation and photodynamic therapy. He has published over 30 articles, with an h-index of 15 and more than 1,300 citations. He received the Claude Leon Fellowship and the University of Johannesburg's Excellence Award. Dr. Kumar serves as Associate Editor for Artificial Cells, Nanomedicine, and Biotechnology and reviews for 11 major publishers.
Dr. Sonaimuthu Mohandoss, a Research Professor and Principal Investigator at Yeungnam University, South Korea, has over 10 years of experience in material chemistry, supramolecular chemistry, organic synthesis, and bioimaging. He earned his Ph.D. from Alagappa University and has published over 75 peer-reviewed articles. His research focuses on organic materials and carbon nanomaterials for chemical sensing, environmental applications, and live-cell imaging, including studies on antiviral drugs for COVID-19. He has received multiple prestigious fellowships and awards, including the MOST Postdoctoral Fellowship (Taiwan), NRF research grants (Korea), and the Korean Chemical Society's Excellence Poster Award in 2022.
作者簡介(中文翻譯)
卡魯普薩米·阿魯納查拉姆博士，巴西聯邦米納斯吉拉斯州大學（UFMS）CeTroGen的訪問教授，專長於民族植物學、民族藥理學、生物技術和臨床前藥理學，專注於草藥藥物開發。他曾在巴西的米納斯吉拉斯聯邦大學（UFMT）擔任博士後研究員，並於2020年獲得中國科學院昆明植物研究所的PIFI獎學金。他最近的研究強調天然產品、植物化學、營養保健品和多醣類。他已發表超過50篇同行評審的文章，撰寫5本書籍（包括3本與Springer Nature合作），7章書籍，並擁有5項專利（4項國際專利和1項國內專利）。
克里希南·阿南德博士是南非自由州大學的高級講師，專長於有機化學、醫學生物化學、藥物發現和納米生物技術。他於2014年在德班科技大學獲得博士學位，並與夸祖魯-納塔爾大學合作。他曾在南非的機構擔任博士後和高級研究職位，並獲得了著名的DSI-NRF創新博士後獎學金。擁有超過2300次引用和26的h指數，他已廣泛發表，包括7本書和20章書籍。他獲得了多項國內和國際獎項，並持有Y1 NRF研究員評級。
薩提什·桑達爾·迪利普·庫馬博士是南非國家研究基金會的C2級納米生物技術研究員，也是約翰尼斯堡大學激光研究中心的高級講師。他是經認證的專業自然科學家（SACNASP）和英國皇家生物學會的成員，他的研究專注於納米顆粒在光生物調制和光動力療法中的應用。他已發表超過30篇文章，擁有15的h指數和超過1300次引用。他獲得了克勞德·里昂獎學金和約翰尼斯堡大學的卓越獎。庫馬博士擔任《人工細胞、納米醫學和生物技術》的副編輯，並為11家主要出版社進行審稿。
索奈穆圖·莫漢多斯博士是韓國慶南大學的研究教授和首席研究員，擁有超過10年的材料化學、超分子化學、有機合成和生物成像經驗。他在阿拉卡帕大學獲得博士學位，並發表了超過75篇同行評審的文章。他的研究專注於有機材料和碳納米材料在化學感測、環境應用和活細胞成像中的應用，包括針對COVID-19的抗病毒藥物研究。他獲得了多項著名的獎學金和獎項，包括台灣的MOST博士後獎學金、韓國的NRF研究補助金，以及2022年韓國化學會的卓越海報獎。
